Thursday, October 30, 2008

Aetna Pushes Do-Overs for Breast Cancer Test

The test determines whether patients may be candidates for Genentech's Herceptin.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)